STOCK TITAN
  1. Home
  2. Sec-filings
  3. KIDS
  4. [Form 4] ORTHOPEDIATRICS CORP Insider Trading Activity

OrthoPediatrics (KIDS) director receives 11,436-share stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Pelizzon David R reported acquisition or exercise transactions in this Form 4 filing.

OrthoPediatrics Corp director David R. Pelizzon received an award of 11,436 shares of common stock on June 9, 2026. The shares were granted at no cost as a stock award, increasing his direct holdings to 44,384 common shares, including 17,959 restricted stock awards.

The filing also reports 6,901,764 common shares held indirectly through Squadron Capital LLC. As President and a member of Squadron’s Managing Committee, Pelizzon may be deemed a beneficial owner, but he expressly disclaims beneficial ownership except for his pecuniary interest.

Positive

  • None.

Negative

  • None.
Insider Pelizzon David R
Role null
Type Security Shares Price Value
Grant/Award Common Stock 11,436 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 44,384 shares (Direct, null); Common Stock — 6,901,764 shares (Indirect, See footnote)
Footnotes (1)
  1. Includes restricted stock awards totaling 17,959 shares. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Stock award size 11,436 shares Common stock grant on June 9, 2026
Award grant price $0.0000 per share Price for 11,436-share stock award
Direct holdings after award 44,384 shares Common stock directly held following transaction
Restricted stock included 17,959 shares Restricted stock awards included in direct holdings
Indirect holdings via Squadron 6,901,764 shares Common stock held indirectly by Squadron Capital LLC
restricted stock awards financial
"Includes restricted stock awards totaling 17,959 shares."
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
beneficial owner financial
"the reporting person may be deemed to be the beneficial owner of these shares."
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
pecuniary interest financial
"except to the extent of his pecuniary interest therein."
Section 16 regulatory
"shall not be deemed to be an admission of beneficial ownership for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
indirect ownership financial
"These shares are held by Squadron Capital LLC ("Squadron")."
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Pelizzon David R
(Last)(First)(Middle)
C/O SQUADRON CAPITAL LLC
18 HARTFORD AVE., PO BOX 223
(Street)
GRANBY CONNECTICUT 06035
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
ORTHOPEDIATRICS CORP [ KIDS ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/09/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/09/2026A11,436A$044,384(1)D
Common Stock6,901,764ISee footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Includes restricted stock awards totaling 17,959 shares.
2. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Remarks:
/s/ Daniel J. Gerritzen, Attorney-in-Fact06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did OrthoPediatrics (KIDS) director David R. Pelizzon report on this Form 4?

Director David R. Pelizzon reported receiving an award of 11,436 OrthoPediatrics common shares. The shares were granted at no cost, increasing his direct holdings to 44,384 shares, which include 17,959 restricted stock awards disclosed in the filing.

How many OrthoPediatrics (KIDS) shares does David R. Pelizzon hold directly after the award?

After the stock award, David R. Pelizzon directly holds 44,384 OrthoPediatrics common shares. This total includes 17,959 shares designated as restricted stock awards, reflecting his direct equity position reported as of the June 9, 2026 transaction date.

What is the size and nature of the stock award to the OrthoPediatrics (KIDS) director?

The OrthoPediatrics director received a stock award of 11,436 common shares. The shares were granted at a price of $0.0000 per share, indicating a compensation-related grant or award rather than an open-market purchase by the director.

Does David R. Pelizzon claim full beneficial ownership of the Squadron Capital OrthoPediatrics (KIDS) shares?

No. Although Pelizzon’s role at Squadron Capital means he may be deemed a beneficial owner of 6,901,764 shares, he expressly disclaims beneficial ownership of those shares, except to the extent of his pecuniary interest, as stated in the footnote.